Yuval Shaked
Yuval Shaked (PhD) is a Professor at the Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion, Israel. He served as the vice dean at his faculty, and also as the director of the Rappaport Technion Integrated Cancer Center (RTICC). He is a former president of the International Cancer Microenvironment Society (ICMS), and current congress president of the federation of the Israeli society for experimental biology (FISEB). He obtained his PhD from the Department of Neurology at Hadassah University Hospital (Israel) where he studied biochemical aspects of neurodegenerative disorders. Subsequently, he was trained at Sunnybrook Health Sciences Centre, University of Toronto, Canada, and studied cancer biology and therapy. In 2008, Prof. Shaked, started his independent academic career at the Faculty of Medicine, Technion, Israel. In his research, Prof. Shaked has pioneered the idea that the host in response to therapy alters the tumor microenvironment sometimes to the tumor advantage, therefore suggesting a double-edged sword of cancer therapy. Prof. Shaked received a number of awards including the Yigal Allon fellowship, Krill Prize from the Wolf foundation, Youdim prize for Excellence in Cancer Research, and the Andre Cohen Deloro Award for scientific achievements. He is supported by national and European grant agencies including ISF and ERC. Prof. Shaked is an author of over 150 published studies. Throughout his career, Prof. Shaked supervised more than 20 graduate students who continued their career in academia or industry. Prof. Shaked is also an entrepreneur and founded two companies in the space of cancer diagnosis and therapy.
Abstracts this author is presenting: